Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Elucidation and Pharmacologic Targeting of Master Regulator Dependencies in Coexisting Diffuse Midline Glioma SubpopulationsEster Calvo Fernández, Lorenzo Tomassoni, Xu Zhang, et al.
Medrxiv : the Preprint Server for Health Sciences|September 24, 2024
Fc-enhanced anti-CTLA-4 depletes tumor-infiltrating regulatory T cells to augment immune effects of androgen ablation in high-risk prostate cancerCasey R Ager, Aleksandar Obradovic, Patrick McCann, et al.
Nature Genetics|April 22, 2026
Systematic design of combination therapy by targeting master regulators of coexisting diffuse midline glioma cell statesEster Calvo Fernández, Lorenzo Tomassoni, Xu Zhang, et al.
Cell Reports. Medicine|February 27, 2026
Neoadjuvant Fc-enhanced anti-CTLA-4 targets Tregs to augment androgen deprivation in high-risk prostate cancer: A randomized phase I trialCasey R Ager, Aleksandar Obradovic, Patrick McCann, et al.
JCO Precision Oncology|June 12, 2026
Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Clinical Models: MEKiAUTOBrian W Labadie, Aleksandar Obradovic, Alexander G Raufi, et al.
European Urology|September 16, 2022
B7-H3 as a Therapeutic Target in Advanced Prostate CancerChristina Guo, Ines Figueiredo, Bora Gurel, et al.
Biorxiv : the Preprint Server for Biology|April 22, 2024
Single Cell Analysis of Treatment-Resistant Prostate Cancer: Implications of Cell State Changes for Cell Surface Antigen Targeted TherapiesSamir Zaidi, Jooyoung Park, Joseph M Chan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2024
Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen-targeted therapiesSamir Zaidi, Jooyoung Park, Joseph M Chan, et al.
Pageof 4